Cycle 7: NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)

Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: July 18, 2017
Award: Actual needs should rarely exceed $1,000,000 in total cost per year during the Phase 1 and $1,500,000 in total costs per year during the Phase 2. 2 years for Phase I and up to 3 years for Phase II.